Peptinovo Biopharma
Ann Arbor, MI
Peptinovo Biopharma Inc. has invented and patented a targeted, drug-delivery platform: Peptide-Amphiphile Lipid Micelle (PALM) that reduces or eliminates chemotherapy-induced peripheral neuropathy (CIPN), one of the most serious side effects threatening treatment outcomes for world-leading chemotherapy drugs like paclitaxel.
peptinovo.comCompany Details
Founded
- 2014
Employees
- Between 5 - 10 employees
Raised
- $1,318,700
Headquarters Location
- Ann Arbor, MI
Public
- No
Acquired
- No
CEO
Steve Tokarz
Founders
- Ren HomanBill Elliott
Company Collections
These are collections Peptinovo Biopharma is a part of. Click on the collection name to view similar companies.